- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 19 - - Initiatives Aim to Control Cardiometabolic Events
During this segment, Yehuda Handelsman, MD, FACP, FACE, FNLA, and Kenneth L. Schaecher, MD, FACP, CPC, discuss how organizations are developing programs that aim to help control diabetes and the obesity epidemic.
Dr Handelsman believes that as clinicians continue to individualize the management of cardiometabolic events and treat patients with single-agents that treat multiple conditions, our country is at the forefront of controlling future events.
For this reason, Dr Schaecher explains the importance of healthcare programs such as the National Diabetes Prevention Program and other nationwide initiatives that provide guidance to clinicians on a local level and force patient involvement. Dr Schaecher expresses that when controlling cardiometabolic events, patient involvement is vital.
Because patient involvement includes localized initiatives, Dr Handelsman and Dr Schaecher conclude their discussion by explaining how community resources are taking steps to ensure patient involvement.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
